Valuation : Acarix AB

Market Cap 298M 31.29M 26.86M 25.14M 23.02M 43.37M 2.99B 43.49M 116M 1.51B 117M 115M 4.98B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 298M 31.29M 26.86M 25.14M 23.02M 43.37M 2.99B 43.49M 116M 1.51B 117M 115M 4.98B EV / Sales 2026 *
21.3x
EV / Sales 2027 * 9.3x
Free-Float
79.69%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 01/02/2024
Chief Executive Officer 62 23/02/2018
Director TitleAgeSince
Director/Board Member 61 01/01/2020
Director/Board Member 52 14/05/2024
Director/Board Member - 14/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
+1.48%+2.80%+29.11%-28.07% 17.96B
-0.71%-2.30%-25.51%+101.29% 1.66B
-2.97%+0.92%-46.88%-80.74% 1.05B
+0.87%-2.93%-24.20%+22.76% 959M
+0.08%-0.05%+61.29%-5.52% 779M
-3.02%-4.58%-35.97%-46.09% 693M
+0.18%-2.01%-42.83%-48.50% 565M
+0.34%+1.77%-37.71%-35.71% 461M
-3.15%-0.42%+69.89%+46.29% 459M
Average -0.77%+3.09%-5.87%-8.25% 2.73B
Weighted average by Cap. +0.78%+1.51%+17.13%-18.62%

Financials

2026 *2027 *
Net sales 14M 1.47M 1.26M 1.18M 1.08M 2.04M 141M 2.05M 5.47M 70.81M 5.52M 5.4M 234M 32M 3.36M 2.89M 2.7M 2.47M 4.66M 321M 4.67M 12.51M 162M 12.62M 12.35M 536M
Net income -30.8M -3.24M -2.78M -2.6M -2.38M -4.49M -309M -4.5M -12.04M -156M -12.15M -11.89M -516M -15.3M -1.61M -1.38M -1.29M -1.18M -2.23M -154M -2.24M -5.98M -77.39M -6.04M -5.91M -256M
Net Debt - -
Logo Acarix AB
Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Company’s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
Employees
-